{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:05:43Z","timestamp":1765807543158,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000837","name":"University of Nottingham","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11906-018-0826-6","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T01:13:32Z","timestamp":1523322812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical and Molecular Features of Thiazide-Induced Hyponatremia"],"prefix":"10.1007","volume":"20","author":[{"given":"Jodie","family":"Nadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarath K.","family":"Channavajjhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian P.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"826_CR1","unstructured":"N.I.C.E. Hypertension: clincial management of primary hypertension in adults. Clinical guideline 2011 [cited 2014 May 1st]; CG127:[Available from: \n                      https:\/\/www.nice.org.uk\/guidance\/cg127\n                      \n                    ."},{"key":"826_CR2","unstructured":"W.H.O., GLOBAL HEALTH RISKS: Mortality and burden of disease attributable to selected major risks. 2009, WHO Press: World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland p 1-70."},{"key":"826_CR3","unstructured":"NHS. Health Survey for England -2006, CVD and risk factors for adults, obesity and risk factors for children. 2006 [cited 2018; Available from: \n                      http:\/\/digital.nhs.uk\/catalogue\/PUB01213\n                      \n                    ."},{"key":"826_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ije\/dyh317","volume":"34","author":"L Dahl","year":"2005","unstructured":"Dahl L. Possible role of salt intake in the development of essential hypertension. Internation Journal of Epidemiology. 2005;34:967\u201372.","journal-title":"Internation Journal of Epidemiology"},{"key":"826_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.jhh.1001459","volume":"16","author":"F He","year":"2002","unstructured":"He F, MacGregor G. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761\u201370.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"826_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1755-5922.2010.00180.x","volume":"29","author":"M Glover","year":"2011","unstructured":"Glover M, Zuber AM, O\u2019Shaughnessy KM. Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovasc Ther. 2011;29(1):68\u201376.","journal-title":"Cardiovasc Ther"},{"key":"826_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/1440-1681.12115","volume":"40","author":"M Glover","year":"2013","unstructured":"Glover M, O\u2019Shaughnessy KM. Molecular insights from dysregulation of the thiazide-sensitive WNK\/SPAK\/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatremia. Clin Exp Pharmacol Physiol. 2013;40:876\u201384.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng0196-24","volume":"12","author":"DB Simon","year":"1996","unstructured":"Simon DB, Nelson-Williams C, Johnson Bia M, Ellison D, Karet FE, Morey Molina A, et al. Gitelman\u2019s variant of Bartter\u2019s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24\u201330.","journal-title":"Nat Genet"},{"issue":"2","key":"826_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/01.HYP.8.2.93","volume":"8","author":"RD Gordon","year":"1986","unstructured":"Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension. 1986;8(2):93\u2013102.","journal-title":"Hypertension"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","volume":"166","author":"E Freis","year":"1958","unstructured":"Freis E, et al. Treatment of essential hypertension with chlorothiazide (diuril): its use alone and combined with other antihypertensive agents. JAMA. 1958;166:137\u201340.","journal-title":"JAMA"},{"key":"826_CR11","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"M Law","year":"2009","unstructured":"Law M, Morris J, Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"key":"826_CR12","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT officers and coordinators for the ALLHAT collaborative research group","year":"2002","unstructured":"The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288:2981\u201397.","journal-title":"JAMA"},{"issue":"7","key":"826_CR13","first-page":"503","volume":"90","author":"C Armstrong","year":"2014","unstructured":"Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503\u20134.","journal-title":"Am Fam Physician"},{"key":"826_CR14","first-page":"2159","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension. Eur Soc Cardiol. 2013;34:2159\u2013219.","journal-title":"Eur Soc Cardiol"},{"key":"826_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/heartjnl-2011-300710","volume":"97","author":"M Brown","year":"2011","unstructured":"Brown M. The choice of diuretic in hypertension: saving the baby from the bathwater. Heart. 2011;97:1457\u2013551.","journal-title":"Heart"},{"issue":"5","key":"826_CR16","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1111\/j.1755-5922.2011.00286.x","volume":"30","author":"M Glover","year":"2012","unstructured":"Glover M, Clayton J. Thiazide-induced hyponatremia: epidemiology and clues to pathogenesis. Cardiovasc Ther. 2012;30(5):e219\u201326.","journal-title":"Cardiovasc Ther"},{"issue":"4","key":"826_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bcp.12499","volume":"79","author":"J Barber","year":"2015","unstructured":"\u2022\u2022 Barber J, McKeever TM, McDowell SE, Clayton JA, Ferner RE, Gordon RD, et al. A systematic review and meta-analysis of thiazide-induced hyponatremia: time to reconsider electrolyte monitoring regimens after thiazide initiation? Br J Clin Pharmacol. 2015;79(4):566\u201377. This is an important publication as it is the first systematic review and meta-analysis of all published TIH cases.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"826_CR18","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1172\/JCI89812","volume":"127","author":"JS Ware","year":"2017","unstructured":"\u2022\u2022 Ware JS, Wain LV, Channavajjhala SK, Jackson VE, Edwards E, Lu R, et al. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. J Clin Invest. 2017;127(9):3367\u201374. This is an important publication as it is the first description of the pharmacogenetics of TIH and also described the phenotype of TIH in detail.","journal-title":"J Clin Invest"},{"key":"826_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/qjmed\/hcl071","volume":"99","author":"JA Clayton","year":"2006","unstructured":"\u2022 Clayton JA, Jeune IRL, Hall IP. Severe hyponatremia in medical in-patients aetiology, assessment and outcome. Q J Med. 2006;99:505\u201311. This describes the aetiology of drug induced hyponatraemia in a large UK teaching hospital and found that TIH is the most frequent.","journal-title":"Q J Med"},{"key":"826_CR20","first-page":"24","volume":"110","author":"E Friedman","year":"1989","unstructured":"\u2022 Friedman E, et al. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Am Coll Phys. 1989;110:24\u201330. This is an important study of thiazide re-challenge in patients who have a history of TIH and showed that it is very reproducible.","journal-title":"Am Coll Phys"},{"issue":"5","key":"826_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","volume":"42","author":"FC Bartter","year":"1967","unstructured":"Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42(5):790\u2013806.","journal-title":"Am J Med"},{"issue":"8","key":"826_CR22","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1210\/jc.2008-0330","volume":"93","author":"W Fenske","year":"2008","unstructured":"Fenske W, St\u00f6rk S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S, et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab. 2008;93(8):2991\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"826_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/pgmj.62.728.449","volume":"62","author":"M Sonnenblick","year":"1986","unstructured":"Sonnenblick M, Rosin AJ. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatremia. Postgrad Med J. 1986;62:449\u201352.","journal-title":"Postgrad Med J"},{"key":"826_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/emmm.200900058","volume":"2","author":"FH Rafiqi","year":"2009","unstructured":"Rafiqi FH, et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med. 2009;2:63\u201375.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"826_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1159\/000471493","volume":"45","author":"V Burst","year":"2017","unstructured":"Burst V, Grundmann F, Kubacki T, Greenberg A, Becker I, Rudolf D, et al. Thiazide-associated hyponatremia, report of the hyponatremia registry: an observational multicenter international study. Am J Nephrol. 2017;45(5):420\u201330.","journal-title":"Am J Nephrol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-018-0826-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:49:52Z","timestamp":1554839392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-018-0826-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s11906-018-0826-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"type":"print","value":"1522-6417"},{"type":"electronic","value":"1534-3111"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"10 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Guidelines"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"31"}}